Haase Michael, Müller Christian, Damman Kevin, Murray Patrick T, Kellum John A, Ronco Claudio, McCullough Peter A
Department of Nephrology and Hypertension, Diabetes and Endocrinology, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Contrib Nephrol. 2013;182:99-116. doi: 10.1159/000349969. Epub 2013 May 13.
Pathophysiological mechanisms of cardiorenal syndromes (CRS) types 1-5 are still sparsely characterized. In an attempt to address this issue, a consensus conference on CRS was held in Venice, Italy, in November 2012 under the auspices of the Acute Dialysis Quality Initiative (ADQI). Working group 1 discussed monodirectional mechanisms of CRS type 1 which is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Pre-conference we performed a systematic search and review of the available literature using a modified Delphi analysis. Hereby identified and in this review discussed questions were: (i) What are the predominant pathophysiologic mechanisms of CRS type 1 in acute decompensated heart failure? (ii) Could biomarker profiling identify pathomechanisms or hemodynamic phenotype of patients with CRS type 1? Could predictive biomarkers improve renal safety of therapy in CRS type 1? (iii) How do the timing, severity and duration relate to the mechanisms and outcomes of CRS type 1? In summary, after discussion and appraisal of the best available evidence, working group 1 makes consensus recommendations for future research on pathologic mechanisms of CRS type 1 and recommendations for clinical practice where treatment is in either proof or disproof of a mechanism.
1-5型心肾综合征(CRS)的病理生理机制仍鲜为人知。为解决这一问题,2012年11月在急性透析质量倡议组织(ADQI)的支持下,在意大利威尼斯召开了一次CRS共识会议。第一工作组讨论了1型CRS的单向机制,其特征是心功能迅速恶化导致急性肾损伤(AKI)。会前,我们使用改良的德尔菲分析法对现有文献进行了系统检索和综述。在此确定并在本综述中讨论的问题有:(i)急性失代偿性心力衰竭中1型CRS的主要病理生理机制是什么?(ii)生物标志物分析能否识别1型CRS患者的病理机制或血流动力学表型?预测性生物标志物能否提高1型CRS治疗的肾脏安全性?(iii)时间、严重程度和持续时间如何与1型CRS的机制和结果相关?总之,在讨论和评估了现有最佳证据后,第一工作组就1型CRS病理机制的未来研究提出了共识性建议,并针对治疗是证实还是否定某种机制的临床实践提出了建议。